UniProt ID | NUP50_HUMAN | |
---|---|---|
UniProt AC | Q9UKX7 | |
Protein Name | Nuclear pore complex protein Nup50 | |
Gene Name | NUP50 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 468 | |
Subcellular Localization |
Nucleus, nuclear pore complex . Nucleus membrane Peripheral membrane protein Nucleoplasmic side . Localizes to the nucleoplasmic fibrils of the nuclear pore complex (By similarity). Dissociates from the NPC structure early during prophase of mito |
|
Protein Description | Component of the nuclear pore complex that has a direct role in nuclear protein import. [PubMed: 20016008 Actively displaces NLSs from importin-alpha, and facilitates disassembly of the importin-alpha:beta-cargo complex and importin recycling] | |
Protein Sequence | MAKRNAEKELTDRNWDQEDEAEEVGTFSMASEEVLKNRAIKKAKRRNVGFESDTGGAFKGFKGLVVPSGGGRFSGFGSGAGGKPLEGLSNGNNITSAPPFASAKAAADPKVAFGSLAANGPTTLVDKVSNPKTNGDSQQPSSSGLASSKACVGNAYHKQLAALNCSVRDWIVKHVNTNPLCDLTPIFKDYEKYLANIEQQHGNSGRNSESESNKVAAETQSPSLFGSTKLQQESTFLFHGNKTEDTPDKKMEVASEKKTDPSSLGATSASFNFGKKVDSSVLGSLSSVPLTGFSFSPGNSSLFGKDTTQSKPVSSPFPTKPLEGQAEGDSGECKGGDEEENDEPPKVVVTEVKEEDAFYSKKCKLFYKKDNEFKEKGIGTLHLKPTANQKTQLLVRADTNLGNILLNVLIPPNMPCTRTGKNNVLIVCVPNPPIDEKNATMPVTMLIRVKTSEDADELHKILLEKKDA | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 (in isoform 2) | Acetylation | - | 21.37 | 22814378 | |
8 | Acetylation | MAKRNAEKELTDRNW CCCCHHHHHHHCCCC | 56.46 | 23749302 | |
8 | Ubiquitination | MAKRNAEKELTDRNW CCCCHHHHHHHCCCC | 56.46 | - | |
31 | Ubiquitination | VGTFSMASEEVLKNR HCCCHHCCHHHHHHH | 26.16 | 21890473 | |
31 | Phosphorylation | VGTFSMASEEVLKNR HCCCHHCCHHHHHHH | 26.16 | 26670566 | |
34 | Ubiquitination | FSMASEEVLKNRAIK CHHCCHHHHHHHHHH | 8.94 | 21890473 | |
52 | Phosphorylation | RRNVGFESDTGGAFK HCCCCCCCCCCCCCC | 37.91 | 30266825 | |
54 | Phosphorylation | NVGFESDTGGAFKGF CCCCCCCCCCCCCCC | 46.96 | 30266825 | |
55 | Ubiquitination | VGFESDTGGAFKGFK CCCCCCCCCCCCCCC | 30.35 | 21890473 | |
55 | Acetylation | VGFESDTGGAFKGFK CCCCCCCCCCCCCCC | 30.35 | 19608861 | |
55 | Ubiquitination | VGFESDTGGAFKGFK CCCCCCCCCCCCCCC | 30.35 | 19608861 | |
55 (in isoform 2) | Ubiquitination | - | 30.35 | - | |
59 | Acetylation | SDTGGAFKGFKGLVV CCCCCCCCCCCEEEE | 64.00 | 25953088 | |
59 | Methylation | SDTGGAFKGFKGLVV CCCCCCCCCCCEEEE | 64.00 | 91125 | |
59 | Ubiquitination | SDTGGAFKGFKGLVV CCCCCCCCCCCEEEE | 64.00 | 21890473 | |
62 | Acetylation | GGAFKGFKGLVVPSG CCCCCCCCEEEECCC | 61.06 | 25953088 | |
62 | Methylation | GGAFKGFKGLVVPSG CCCCCCCCEEEECCC | 61.06 | 44497529 | |
62 | Ubiquitination | GGAFKGFKGLVVPSG CCCCCCCCEEEECCC | 61.06 | 21890473 | |
68 | Phosphorylation | FKGLVVPSGGGRFSG CCEEEECCCCCCCCC | 38.16 | 25159151 | |
74 | Phosphorylation | PSGGGRFSGFGSGAG CCCCCCCCCCCCCCC | 31.67 | 25159151 | |
76 (in isoform 2) | Ubiquitination | - | 7.34 | - | |
78 | Phosphorylation | GRFSGFGSGAGGKPL CCCCCCCCCCCCCCC | 24.17 | 25159151 | |
82 (in isoform 2) | Ubiquitination | - | 28.07 | - | |
83 | Acetylation | FGSGAGGKPLEGLSN CCCCCCCCCCCCCCC | 45.57 | 19608861 | |
83 | Ubiquitination | FGSGAGGKPLEGLSN CCCCCCCCCCCCCCC | 45.57 | 21906983 | |
99 | Ubiquitination | NNITSAPPFASAKAA CCCCCCCCCCCCHHH | 36.83 | 21890473 | |
99 (in isoform 2) | Ubiquitination | - | 36.83 | - | |
104 | Ubiquitination | APPFASAKAAADPKV CCCCCCCHHHCCCCE | 35.74 | 21890473 | |
110 | Ubiquitination | AKAAADPKVAFGSLA CHHHCCCCEEEHHHH | 46.90 | 21890473 | |
115 | Phosphorylation | DPKVAFGSLAANGPT CCCEEEHHHHCCCCC | 14.37 | 19060867 | |
122 | Phosphorylation | SLAANGPTTLVDKVS HHHCCCCCEEEECCC | 33.87 | 24972180 | |
123 | Phosphorylation | LAANGPTTLVDKVSN HHCCCCCEEEECCCC | 28.11 | 24972180 | |
127 | Acetylation | GPTTLVDKVSNPKTN CCCEEEECCCCCCCC | 39.83 | 25953088 | |
127 | Ubiquitination | GPTTLVDKVSNPKTN CCCEEEECCCCCCCC | 39.83 | 21890473 | |
132 | Ubiquitination | VDKVSNPKTNGDSQQ EECCCCCCCCCCCCC | 59.89 | - | |
133 | Phosphorylation | DKVSNPKTNGDSQQP ECCCCCCCCCCCCCC | 45.77 | 20068231 | |
137 | Phosphorylation | NPKTNGDSQQPSSSG CCCCCCCCCCCCCCC | 31.92 | 20068231 | |
141 | Phosphorylation | NGDSQQPSSSGLASS CCCCCCCCCCCCCCC | 32.57 | 20068231 | |
142 | Phosphorylation | GDSQQPSSSGLASSK CCCCCCCCCCCCCCC | 34.80 | 20068231 | |
143 | Phosphorylation | DSQQPSSSGLASSKA CCCCCCCCCCCCCCH | 42.01 | 25159151 | |
147 | Phosphorylation | PSSSGLASSKACVGN CCCCCCCCCCHHHHH | 37.10 | 20068231 | |
148 | Phosphorylation | SSSGLASSKACVGNA CCCCCCCCCHHHHHH | 20.75 | 20068231 | |
149 | Acetylation | SSGLASSKACVGNAY CCCCCCCCHHHHHHH | 43.22 | 26051181 | |
158 | Acetylation | CVGNAYHKQLAALNC HHHHHHHHHHHHHCC | 34.04 | 23749302 | |
158 | Malonylation | CVGNAYHKQLAALNC HHHHHHHHHHHHHCC | 34.04 | 26320211 | |
158 | Ubiquitination | CVGNAYHKQLAALNC HHHHHHHHHHHHHCC | 34.04 | - | |
164 | Ubiquitination | HKQLAALNCSVRDWI HHHHHHHCCCHHHHH | 15.99 | 21890473 | |
164 (in isoform 2) | Ubiquitination | - | 15.99 | - | |
173 | Acetylation | SVRDWIVKHVNTNPL CHHHHHHHHCCCCCC | 32.47 | 23954790 | |
173 | Ubiquitination | SVRDWIVKHVNTNPL CHHHHHHHHCCCCCC | 32.47 | - | |
181 | Glutathionylation | HVNTNPLCDLTPIFK HCCCCCCCCCCHHHC | 4.20 | 22555962 | |
184 | Phosphorylation | TNPLCDLTPIFKDYE CCCCCCCCHHHCCHH | 10.90 | - | |
188 | Acetylation | CDLTPIFKDYEKYLA CCCCHHHCCHHHHHH | 61.18 | 26051181 | |
188 | Ubiquitination | CDLTPIFKDYEKYLA CCCCHHHCCHHHHHH | 61.18 | - | |
192 | Acetylation | PIFKDYEKYLANIEQ HHHCCHHHHHHHHHH | 39.06 | 25953088 | |
192 | Ubiquitination | PIFKDYEKYLANIEQ HHHCCHHHHHHHHHH | 39.06 | 21890473 | |
193 | Phosphorylation | IFKDYEKYLANIEQQ HHCCHHHHHHHHHHH | 10.10 | 26074081 | |
201 | Ubiquitination | LANIEQQHGNSGRNS HHHHHHHHCCCCCCC | 36.78 | 21890473 | |
204 | Phosphorylation | IEQQHGNSGRNSESE HHHHHCCCCCCCHHH | 43.66 | 25159151 | |
208 | Phosphorylation | HGNSGRNSESESNKV HCCCCCCCHHHHHHH | 40.93 | 25159151 | |
210 | Phosphorylation | NSGRNSESESNKVAA CCCCCCHHHHHHHHH | 46.26 | 28450419 | |
212 | Phosphorylation | GRNSESESNKVAAET CCCCHHHHHHHHHHC | 51.75 | 28464451 | |
214 | Ubiquitination | NSESESNKVAAETQS CCHHHHHHHHHHCCC | 42.40 | - | |
219 | Phosphorylation | SNKVAAETQSPSLFG HHHHHHHCCCCHHCC | 29.62 | 30266825 | |
221 | Phosphorylation | KVAAETQSPSLFGST HHHHHCCCCHHCCCC | 24.71 | 29255136 | |
223 | Phosphorylation | AAETQSPSLFGSTKL HHHCCCCHHCCCCCC | 41.39 | 19664994 | |
227 | Phosphorylation | QSPSLFGSTKLQQES CCCHHCCCCCCEEEE | 18.29 | 25159151 | |
228 | Phosphorylation | SPSLFGSTKLQQEST CCHHCCCCCCEEEEE | 35.83 | 25159151 | |
229 | Acetylation | PSLFGSTKLQQESTF CHHCCCCCCEEEEEE | 46.10 | 25953088 | |
229 | Ubiquitination | PSLFGSTKLQQESTF CHHCCCCCCEEEEEE | 46.10 | 21890473 | |
230 | Ubiquitination | SLFGSTKLQQESTFL HHCCCCCCEEEEEEE | 6.87 | 21890473 | |
234 | Phosphorylation | STKLQQESTFLFHGN CCCCEEEEEEEECCC | 21.81 | 30576142 | |
235 | Phosphorylation | TKLQQESTFLFHGNK CCCEEEEEEEECCCC | 24.49 | 28555341 | |
242 | Acetylation | TFLFHGNKTEDTPDK EEEECCCCCCCCCCC | 58.86 | 26051181 | |
242 | Ubiquitination | TFLFHGNKTEDTPDK EEEECCCCCCCCCCC | 58.86 | - | |
243 | Phosphorylation | FLFHGNKTEDTPDKK EEECCCCCCCCCCCC | 42.99 | 30576142 | |
246 | Phosphorylation | HGNKTEDTPDKKMEV CCCCCCCCCCCCCCH | 27.44 | 25159151 | |
247 | Acetylation | GNKTEDTPDKKMEVA CCCCCCCCCCCCCHH | 64.84 | 19608861 | |
247 (in isoform 2) | Ubiquitination | - | 64.84 | - | |
249 | Acetylation | KTEDTPDKKMEVASE CCCCCCCCCCCHHHC | 56.05 | 23749302 | |
255 | Phosphorylation | DKKMEVASEKKTDPS CCCCCHHHCCCCCHH | 55.94 | 21815630 | |
258 | Ubiquitination | MEVASEKKTDPSSLG CCHHHCCCCCHHHCC | 54.85 | 21890473 | |
259 | Phosphorylation | EVASEKKTDPSSLGA CHHHCCCCCHHHCCC | 65.30 | 25159151 | |
262 | Phosphorylation | SEKKTDPSSLGATSA HCCCCCHHHCCCCEE | 40.79 | 22199227 | |
263 | Phosphorylation | EKKTDPSSLGATSAS CCCCCHHHCCCCEEE | 35.89 | 25159151 | |
267 | Phosphorylation | DPSSLGATSASFNFG CHHHCCCCEEEECCC | 24.03 | 20068231 | |
268 | O-linked_Glycosylation | PSSLGATSASFNFGK HHHCCCCEEEECCCC | 22.75 | 30059200 | |
268 | Phosphorylation | PSSLGATSASFNFGK HHHCCCCEEEECCCC | 22.75 | 25159151 | |
270 | Phosphorylation | SLGATSASFNFGKKV HCCCCEEEECCCCCC | 22.08 | 25159151 | |
275 | 2-Hydroxyisobutyrylation | SASFNFGKKVDSSVL EEEECCCCCCCHHHH | 45.55 | - | |
275 | Acetylation | SASFNFGKKVDSSVL EEEECCCCCCCHHHH | 45.55 | 23954790 | |
275 | Methylation | SASFNFGKKVDSSVL EEEECCCCCCCHHHH | 45.55 | 19608861 | |
275 | Ubiquitination | SASFNFGKKVDSSVL EEEECCCCCCCHHHH | 45.55 | 19608861 | |
279 | Phosphorylation | NFGKKVDSSVLGSLS CCCCCCCHHHHHCCC | 25.90 | 23090842 | |
280 | Phosphorylation | FGKKVDSSVLGSLSS CCCCCCHHHHHCCCC | 19.52 | 23090842 | |
284 | O-linked_Glycosylation | VDSSVLGSLSSVPLT CCHHHHHCCCCCCCC | 22.40 | 30059200 | |
284 | Phosphorylation | VDSSVLGSLSSVPLT CCHHHHHCCCCCCCC | 22.40 | 23090842 | |
286 | Phosphorylation | SSVLGSLSSVPLTGF HHHHHCCCCCCCCEE | 30.87 | 23090842 | |
287 | Phosphorylation | SVLGSLSSVPLTGFS HHHHCCCCCCCCEEE | 32.80 | 23090842 | |
291 | Phosphorylation | SLSSVPLTGFSFSPG CCCCCCCCEEEECCC | 30.06 | 28450419 | |
294 | Phosphorylation | SVPLTGFSFSPGNSS CCCCCEEEECCCCCC | 26.59 | 22115753 | |
296 | Phosphorylation | PLTGFSFSPGNSSLF CCCEEEECCCCCCCC | 30.60 | 25159151 | |
300 | Phosphorylation | FSFSPGNSSLFGKDT EEECCCCCCCCCCCC | 34.04 | 22115753 | |
301 | Phosphorylation | SFSPGNSSLFGKDTT EECCCCCCCCCCCCC | 31.55 | 28450419 | |
305 | Ubiquitination | GNSSLFGKDTTQSKP CCCCCCCCCCCCCCC | 44.56 | - | |
307 | Phosphorylation | SSLFGKDTTQSKPVS CCCCCCCCCCCCCCC | 30.16 | 30576142 | |
308 | Phosphorylation | SLFGKDTTQSKPVSS CCCCCCCCCCCCCCC | 40.76 | 25394399 | |
310 | Phosphorylation | FGKDTTQSKPVSSPF CCCCCCCCCCCCCCC | 36.51 | 30576142 | |
311 | Acetylation | GKDTTQSKPVSSPFP CCCCCCCCCCCCCCC | 39.35 | 23954790 | |
314 | Phosphorylation | TTQSKPVSSPFPTKP CCCCCCCCCCCCCCC | 40.60 | 29255136 | |
315 | Phosphorylation | TQSKPVSSPFPTKPL CCCCCCCCCCCCCCC | 30.69 | 29255136 | |
318 (in isoform 2) | Ubiquitination | - | 42.78 | - | |
319 | Phosphorylation | PVSSPFPTKPLEGQA CCCCCCCCCCCCCCC | 45.75 | 29255136 | |
320 | Acetylation | VSSPFPTKPLEGQAE CCCCCCCCCCCCCCC | 48.09 | 26051181 | |
320 | Ubiquitination | VSSPFPTKPLEGQAE CCCCCCCCCCCCCCC | 48.09 | - | |
325 (in isoform 2) | Ubiquitination | - | 27.19 | - | |
330 | Phosphorylation | EGQAEGDSGECKGGD CCCCCCCCCCCCCCC | 47.55 | 29255136 | |
346 | Ubiquitination | EENDEPPKVVVTEVK CCCCCCCCEEEEEEC | 59.38 | 21890473 | |
353 | Sumoylation | KVVVTEVKEEDAFYS CEEEEEECHHHHHHH | 49.51 | - | |
353 | Sumoylation | KVVVTEVKEEDAFYS CEEEEEECHHHHHHH | 49.51 | 28112733 | |
353 | Ubiquitination | KVVVTEVKEEDAFYS CEEEEEECHHHHHHH | 49.51 | 21890473 | |
364 | Acetylation | AFYSKKCKLFYKKDN HHHHCCCEEEEECCC | 50.97 | 26051181 | |
376 | Ubiquitination | KDNEFKEKGIGTLHL CCCCHHHCCCEEEEE | 57.32 | - | |
384 | Acetylation | GIGTLHLKPTANQKT CCEEEEECCCCCCCE | 29.58 | 25953088 | |
399 | Phosphorylation | QLLVRADTNLGNILL EEEEECCCCCCCHHH | 31.21 | 20068231 | |
432 | Ubiquitination | LIVCVPNPPIDEKNA EEEECCCCCCCCCCC | 22.58 | 21890473 | |
450 | Acetylation | VTMLIRVKTSEDADE EEEEEEEECCCCHHH | 36.16 | 27452117 | |
460 | Acetylation | EDADELHKILLEKKD CCHHHHHHHHHHHHC | 47.90 | 25953088 | |
460 | Ubiquitination | EDADELHKILLEKKD CCHHHHHHHHHHHHC | 47.90 | 21890473 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
221 | S | Phosphorylation | Kinase | CDK1 | P06493 | PSP |
221 | S | Phosphorylation | Kinase | MAPK1 | P28482 | GPS |
221 | S | Phosphorylation | Kinase | MAPK3 | P27361 | GPS |
315 | S | Phosphorylation | Kinase | MAPK1 | P28482 | GPS |
315 | S | Phosphorylation | Kinase | MAPK3 | P27361 | GPS |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of NUP50_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of NUP50_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-83, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-221, AND MASSSPECTROMETRY. | |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-221, AND MASSSPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-221, AND MASSSPECTROMETRY. | |
"Global proteomic profiling of phosphopeptides using electron transferdissociation tandem mass spectrometry."; Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A.; Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-219 AND SER-221, ANDMASS SPECTROMETRY. | |
"A probability-based approach for high-throughput proteinphosphorylation analysis and site localization."; Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.; Nat. Biotechnol. 24:1285-1292(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-221, AND MASSSPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-221, AND MASSSPECTROMETRY. |